Screen Selection Sample Clauses
Screen Selection. Attached as Exhibit 1.35 is a list of at least *** Organon Targets for ***. Additional potential Organon Targets (at least *** and of *** listed on Exhibit A, with a *** by ***; i.e *** and *** or ***, e.g., ***, etc.) will be presented by Organon to Aurora at *** days prior to the *** of the Effective Date during the Collaboration Period. Aurora will develop Collaborative Screens for at least *** Organon Targets (of which *** unless otherwise agreed by the CSP Steering Committee) in the ***, of the Collaborative Period, *** Collaborative Screens for Organon Targets (of which *** may be *** unless otherwise agreed by the CSP Steering Committee) in the *** of the Collaborative Period, subject to Sections 2.1.3.3 and 2.1.3.4. *** Confidential Treatment Requested
9 2.1.2.1. The *** listed in Exhibit A and *** Organon shall be *** Organon reasonably *** using Aurora Technology. Aurora may reasonably request further information regarding ***. Within *** of first receiving such information, Aurora shall notify Organon in writing in the event that Aurora reasonably *** is *** obligations or if Aurora *** for a *** would not reasonably be scientifically *** based on available information and that ***. If Aurora *** proposed by ***, Aurora will *** Organon ***, to the extent that Aurora does not have to reveal confidential *** Third Party. Consequently, the parties agree that in some instances Aurora *** a ***.
Screen Selection. Attached as Exhibit A is a list of ***P&U Targets for Collaborative Screen development. Additional potential P&U Targets may be presented by P&U to Aurora during the Collaboration Period. The ***and those subsequently proposed in writing by P&U ***that P&U reasonably believes to be amenable for development for a high throughput screen using Aurora Technology. Aurora may reasonably request further information regarding the ***. Within ***days of first receiving such information, Aurora shall notify P&U in writing in the event that Aurora reasonably believes that the development of a Collaborative Screen ***is not consistent with Aurora's Third Party obligations or if Aurora believes that the development of a *** not reasonably be scientifically ***feasible based on available information and that information provided by P&U. If Aurora *** proposed by P&U, Aurora will provide P&U with reasons for declining to work on the proposed target, to the extent that Aurora does not have to reveal confidential information of a Third Party, waive attorney client privilege ***. Consequently, ***Aurora may not have to provide ***.
Screen Selection. Within fifteen (15) days after the Effective Date, and at least ninety (90) days prior to the first, second, third and fourth anniversaries of the Effective Date, Merck will propose in writing to Aurora molecular targets which Merck believes are reasonably feasible for development of screens for the next Annual Work Plan. For each proposed molecular target, Merck shall provide Aurora with a written proposal describing such molecular target. Within thirty (30) days after the Effective Date, and in subsequent years, within forty-five (45) days after receiving such information from Merck, and further information as Aurora may reasonably request regarding a proposed molecular target, Aurora shall provide to Merck an estimate of the approximate resources required for such screen development and shall notify Merck as to whether Aurora accepts such proposed target; provided, however, that Aurora may only reject a proposed target if it reasonably believes that the development of a Collaborative Screen for such proposed target (i) would be inconsistent with Aurora's Third Party obligations, (ii) would cause Aurora to infringe the intellectual property rights of a Third Party, (iii) would require more than two FTEs for twelve months or (iv) would not be feasible in view of the resources and expertise required to complete such Collaborative Screen . Merck and Aurora will repeat the foregoing selection procedure ("Selection Procedure") and will use reasonable efforts, to select at least three (3) molecular targets, for the Annual Work Plan for each year, for which screen development shall be initiated ***.
Screen Selection. Within *** of the Effective Date PD will begin to propose in writing to Aurora molecular targets. For each proposed molecular target, PD shall provide Aurora with a written proposal describing such target. Within thirty (30) days of receiving such information, and further information as Aurora may
Screen Selection